Status:
UNKNOWN
Efficacy of Accelerated Versus Standard Regiment of Hepatitis B Virus Vaccine Among Inflammatory Bowel Disease Patients
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that includes ulcerative colitis (UC) and Crohn's disease (CD) . They mainly affect young populations,...
Detailed Description
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract that includes ulcerative colitis (UC) and Crohn's disease (CD) . They mainly affect young populations,...
Eligibility Criteria
Inclusion
- IBD patients with negative HBs Ag and HBsAb less than 10
Exclusion
- Patients who refuse enter the study
- Patients who already have HBV infection
- Patients who had HBV vaccine recently
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05967650
Start Date
September 1 2023
End Date
October 1 2024
Last Update
August 1 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.